GlobalGov › United States › Award

MERIDIAN BIOSCIENCE INC won RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROJECT #6139: REVOGENE SARS-COV-2 ASSAY from National Institutes of Health

National Institutes of Health · United States government award

GlobalGov surfaces government contract awards from around the world, including the markets your competitors overlook.

$6.2M
Award Value
May 8, 2025
Award Date
Awarded
Status

Award Overview

MERIDIAN BIOSCIENCE INC was awarded RAPID ACCELERATION OF DIAGNOSTICS (RADX) TECH PROJECT #6139: REVOGENE SARS-COV-2 ASSAY by National Institutes of Health in United States, tracked by GlobalGov. The award is valued at $6.2M. It was awarded on May 8, 2025. Classification: NAICS 334516, PSC Q301. Full award details and the issuing agency are below.

See who is winning government contracts in this market — and the open opportunities coming next. Track awards, incumbents, and recompetes worldwide. Free for 14 days, no card.

Start Free

Award Details

AwardeeMERIDIAN BIOSCIENCE INC
Awardee countryUnited States
Awarding agencyNational Institutes of Health
CountryUnited States
Award value$6.2M
Award dateMay 8, 2025
NAICS334516
PSCQ301
Place of performanceUnited States
Last verifiedSeptember 2, 2026

Source: U.S. Government (USAspending.gov) — public domain. GlobalGov is not affiliated with or endorsed by the United States Government.

United States market overview →Browse open opportunities →

Track every United States contract award and the opportunities behind them. Free for 14 days.

Get incumbent intelligence, recompete alerts, and deadline tracking for this market and every market worldwide.

Start Free Trial — No Card Required

Free 14-day trial · no card required